Concentrations of propofol in cerebral spinal fluid: Target-controlled infusion

Chinese Medical Journal

Volumn 117, Issue 2, 2004, Pages 231-234

  Luo, Ai Lun ^a   Yi, Jie ^a   Guo, Xiang Yang ^a   Ren, Hong Zhi ^a   Huang, Yu Guang ^a   Ye, Tie Hu ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Cerebral spinal fluid; Concentration; Propofol; Target controlled infusion

Indexed keywords

PROPOFOL;

ARTICLE; BISPECTRAL INDEX; BLOOD SAMPLING; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOG; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG INFUSION; DRUG TARGETING; FLUORESCENCE ANALYSIS; HEMODYNAMICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ANESTHETICS, INTRAVENOUS; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOGS; INFUSIONS, INTRAVENOUS; PROPOFOL;

EID: 1542581405     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Struys MR, Tom DS, Birgit D, et al. Comparison of plasma compartment versus two methods for effect compartment-controlled target-controlled infusion for propofol. Anesthesiology 2000;92:399-406.
2. Plummer GF. Improved method for the determination of propofol in blood by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987;421:171-176.
3. Schwilden H. A general method for calculating the dosage scheme in linear pharmacokinetics. Eur J Clin Pharmacol 1981;20:379-386.
4. Shafer SL, Gregg KM. Algorithms to rapidly achieve and maintain stable drug concentrations at the site of drug effect with a computer-controlled infusion pump. J Pharmacokinet Biopharmaceu 1992;20:147-169.
5. Jacobs JR, Williams EA. Algorithms to control effect compartment drug concentrations in pharmacokinetic model-driven drug delivery. Trans Biomed Eng 1993;40:993-999.
6. Wakeling HG, Zieran JB, Howell S, et al. Targeting effect compartment or central compartment concentration for propofol, which predicted the loss of consciousness? Anesthesiology 1999;90:92-97.
7. Zhu CG. Central nerve System. In: Yu P, eds. System anatomy. 4th. Beijing: People's Health Press;1998:384.
8. Dutta S. Factors affecting the assessment of CNS pharmacodynamics. Buffalo: Department of Pharmaceutics, State University of New York;1998.
9. Servin F, Desmonts JM, Haberer JP, et al. Pharmacokinetics and protein bindings of propofol in patients with cirrhosis. Anesthes Anaesthesiol 1988;69:887-890.
10. Fragen RJ. Infusions of intravenous anesthetics. In: Fragen RJ, eds. Anesthesiology: Drug infusion. New York: Raven Press;1991:63-84.
11. Varvel JR, Donoho DL, Shafer SL. Measuring the predictive performance of computer-controlled infusion pumps. J Pharmacokinet Biopharm 1992;20:63-94.
12. Swinhoe CF, Peacock JE, Glen JB, et al. Evaluation of the predictive performance of a DIPRIFUSOR TCI system. Anaesthesia 1998;53(Suppl):61-67.
13. Glen JB. The development of "DIprifusor": A TCI system for propofol. Anaesthesia 1998;53( Suppl):13-21.
14. Engdahl O, Abrahams M, Bjornsson A, et al. Cerebrospinal fluid concentrations of propofol during anaesthesia in humans. Br J Anaesthesia 1998;81:957-959.
15. Sheiner LB, Stanski DR, Vozeh S, et al. Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d-tubocurarine. Clin Pharmacol Ther 1979;25: 358-371.
16. Holford NHG, Sheiner LB. Understanding the dose-effect relationship: Clinical application of pharmacokinetic-pharmacodynamic models. Clin Pharmacokinet 1981;6:429-453.